Old Web
English
Sign In
Acemap
>
authorDetail
>
G F Tidmarsh
G F Tidmarsh
Medicine
Pathology
Cancer
Nuclear medicine
Breast cancer
6
Papers
333
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
End-tidal carbon monoxide and hemolysis
2014
Journal of Perinatology
G F Tidmarsh
Ronald J. Wong
David K. Stevenson
Show All
Source
Cite
Save
Citations (29)
Discriminatory power of the 111-indium scan (111-In) in the prediction of altered biodistribution of radio-immunoconjugate in the 90-yttrium ibritumomab tiuxetan therapeutic regimen: Meta-analysis of five clinical trials and 9 years of post-approval safety data.
2011
Journal of Clinical Oncology
J. W. Kylstra
Thomas Elmer Witzig
M. Huang
C. E. Emmanouilides
Anton Hagenbeek
G F Tidmarsh
Show All
Source
Cite
Save
Citations (5)
Single-agent activity of GCS-100, a first-in-class galectin-3 antagonist, in elderly patients with relapsed chronic lymphocytic leukemia
2009
Journal of Clinical Oncology
Finbarr E. Cotter
David Smith
Thomas E. Boyd
Donald A. Richards
Carlos Alemany
D. Loesch
G. Salogub
G F Tidmarsh
G M Gammon
John G. Gribben
Show All
Source
Cite
Save
Citations (18)
An open label phase II trial of glufosfamide: A {beta}-D-glucose-linked isophosphoramide mustard given as 1-hour infusion in patients with advanced breast cancer
2004
Journal of Clinical Oncology
G F Tidmarsh
I. O. Kudajbergenova
S. N. Navrusov
V.V. Stepula
Show All
Source
Cite
Save
Citations (4)
In Vivo Anticoagulant Properties of a Novel Nucleotide-Based Thrombin Inhibitor and Demonstration of Regional Anticoagulation in Extracorporeal Circuits
1993
Blood
L C Griffin
G F Tidmarsh
Louis C. Bock
John J. Toole
Lawrence L. K. Leung
Show All
Source
Cite
Save
Citations (223)
1